Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BNTX – BioNTech SE

BioNTech SE
BNTX
$108.49
Name : BioNTech SE
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $26,080,235,520.00
EPSttm : -3.65
finviz dynamic chart for BNTX
BioNTech SE
$108.49
1.51%
$1.66

Float Short %

2.27

Margin Of Safety %

Put/Call OI Ratio

0.79

EPS Next Q Diff

0.99

EPS Last/This Y

-1.11

EPS This/Next Y

-0.57

Price

108.42

Target Price

138.13

Analyst Recom

1.52

Performance Q

-0.27

Relative Volume

0.92

Beta

1.27

Ticker: BNTX




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-08BNTX94.70.721.8057760
2025-05-09BNTX92.820.724.4358410
2025-05-12BNTX97.290.721.4758429
2025-05-13BNTX94.540.710.7658682
2025-05-14BNTX920.710.1558752
2025-05-15BNTX92.340.713.0458668
2025-05-16BNTX92.780.700.3358490
2025-05-19BNTX97.850.731.8349459
2025-05-20BNTX101.70.770.1451971
2025-05-21BNTX99.20.720.8354324
2025-05-22BNTX99.080.730.5554409
2025-05-23BNTX98.70.720.3154198
2025-05-27BNTX98.60.710.1155257
2025-05-28BNTX97.490.700.0256102
2025-05-29BNTX100.30.690.1456617
2025-05-30BNTX95.830.670.7257362
2025-06-02BNTX113.20.670.8857319
2025-06-03BNTX115.620.700.3859523
2025-06-04BNTX111.140.770.8858069
2025-06-05BNTX110.10.780.7759843
2025-06-06BNTX108.410.793.2059737
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-08BNTX94.7724.5-1438.1-5.25
2025-05-09BNTX92.7624.5-1131.3-5.25
2025-05-12BNTX97.2724.5-1602.0-5.25
2025-05-13BNTX94.5424.5-1074.0-5.25
2025-05-14BNTX92.0824.5-1029.2-5.25
2025-05-15BNTX92.2524.5-1237.7-5.25
2025-05-16BNTX92.8123.5-1258.2-5.31
2025-05-19BNTX97.8023.5-1602.8-5.31
2025-05-20BNTX101.7223.5-1507.8-5.31
2025-05-21BNTX99.1823.5-1137.8-5.31
2025-05-22BNTX99.0822.9-1269.3-5.50
2025-05-23BNTX98.6523.4-1278.9-5.49
2025-05-27BNTX98.5523.4-1277.4-5.49
2025-05-28BNTX97.4323.4-1253.1-5.49
2025-05-29BNTX100.2323.4-1483.2-5.49
2025-05-30BNTX95.8123.4-1004.3-5.49
2025-06-02BNTX113.1723.9-2530.2-5.44
2025-06-03BNTX115.6423.9-1378.7-5.44
2025-06-04BNTX111.0423.9-1094.5-5.44
2025-06-05BNTX110.1539.3-1270.3-4.56
2025-06-06BNTX108.4239.3-1245.2-4.26
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-08BNTX0.0013.511.83
2025-05-09BNTX0.0013.511.83
2025-05-12BNTX0.0014.781.96
2025-05-13BNTX0.0014.781.96
2025-05-14BNTX0.0014.781.96
2025-05-15BNTX0.0014.781.96
2025-05-16BNTX0.0014.781.96
2025-05-19BNTX0.0011.311.96
2025-05-20BNTX0.0011.311.96
2025-05-21BNTX0.0011.311.96
2025-05-22BNTX0.0011.311.96
2025-05-23BNTX0.0011.311.96
2025-05-27BNTX0.001.811.96
2025-05-28BNTX0.001.812.27
2025-05-29BNTX0.001.812.27
2025-05-30BNTX0.001.812.27
2025-06-02BNTX0.001.812.27
2025-06-03BNTX0.001.812.27
2025-06-04BNTX0.001.812.27
2025-06-05BNTX0.001.812.27
2025-06-06BNTX0.001.812.27
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-1.82

Avg. EPS Est. Current Quarter

-1.67

Avg. EPS Est. Next Quarter

-0.83

Insider Transactions

Institutional Transactions

1.81

Beta

1.27

Average Sales Estimate Current Quarter

147

Average Sales Estimate Next Quarter

724

Fair Value

Quality Score

58

Growth Score

36

Sentiment Score

71

Actual DrawDown %

76.6

Max Drawdown 5-Year %

-82.2

Target Price

138.13

P/E

Forward P/E

PEG

P/S

8.79

P/B

1.28

P/Free Cash Flow

EPS

-3.44

Average EPS Est. Cur. Y​

-4.26

EPS Next Y. (Est.)

-4.83

Target Price Estimates Raised

2

Target Price Estimates Lowered

Profit Margin

-27.39

Relative Volume

0.92

Return on Equity vs Sector %

-28.1

Return on Equity vs Industry %

-10.1

EPS 1 7Days Diff

1.1

EPS 1 30Days Diff

0.86

EBIT Estimation

-1245.2
BioNTech SE
Sector: Healthcare
Industry: Biotechnology
Employees: 6772
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical trial for solid tumors; BNT152+BNT153, which is in phase 1 clinical trial for solid tumors; and BNT122/RO7198457, which is in Phase 2 clinical trial to treat adjuvant high-risk muscle-invasive urothelial carcinoma, colorectal cancer, pancreatic ductal adenocarcinoma, advance melanoma, as well as in phase 1a/1b clinical trial for advanced/metastatic solid tumors. It also develops BNT211, which is in phase 1 clinical trial to treat CLDN6+ solid tumors; BNT221, phase 1 clinical trial for the treatment of cancer; BNT311/GEN1046 (acasunlimab), which is in phase 3 clinical trial for solid tumors; BNT312/GEN1042, which is in phase 1/2 and 1 clinical trial to treat solid tumors; BNT314/GEN1059, which is in Phase 1/2 clinical trial for advanced or metastatic solid tumors; BNT315/GEN1055, which is in phase 1/2 clinical trial for advanced solid tumors; BNT317, which is in phase 1 clinical trial for advanced solid tumors; BNT327, which is in phase 1/2, 2, and 3 clinical trial to treat small cell lung cancer, advanced/metastatic tnbc, neuroendocrine neoplasm, malignant mesothelioma, EGFR-mutant non-squamous, hepatocellular carcinoma, and advanced solid tumors; and BNT316/ONC-392, which is in phase 1/2, 2, and 3 clinical trial to treat metastatic, non-small cell lung cancer, platinum-resistant ovarian cancer, metastatic castration resistant prostate cancer, and advanced or metastatic solid tumor. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.
stock quote shares BNTX – BioNTech SE Stock Price stock today
news today BNTX – BioNTech SE stock forecast ,stock prediction 2023 2024 2025
marketwatch BNTX – BioNTech SE yahoo finance google finance
stock history BNTX – BioNTech SE invest stock market
stock prices BNTX premarket after hours
ticker BNTX fair value insiders trading